Pentixapharm Holding AG (ETR:PTP)
Germany flag Germany · Delayed Price · Currency is EUR
1.890
-0.015 (-0.79%)
At close: Aug 4, 2026

Pentixapharm Holding AG Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024
Period EndingMar '26 Dec '25 Dec '24
Revenue
0.070.096.82
Revenue Growth
--98.64%-
Gross Profit
0.070.096.82
Operating Income
-18.76-19.86-16.97
Net Income
-15.68-16.51-11.93
Earnings Per Share
-0.64-0.67-0.52
EPS Growth
---

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024
Period EndingMar '26 Dec '25 Dec '24
Net Cash (Debt)
5.164.6223.23
Net Cash Growth
-70.31%-80.10%-
Cash & Investments
5.164.6223.23
Net Cash Per Share
0.210.190.94

Cash Flow & CapEx

Fiscal YearTTMFY 2025
Period EndingMar '26 Dec '25
Operating Cash Flow
-15.2-17.97
Free Cash Flow
-15.2-17.97
Free Cash Flow Growth
--

Margins

Fiscal YearTTMFY 2025FY 2024
Period EndingMar '26 Dec '25 Dec '24
Gross Margin
100.00%100.00%100.00%
Operating Margin
-25347.30%-21354.80%-248.93%
Pretax Margin
-25112.16%-20981.72%-242.74%
Profit Margin
-21187.80%-17753.80%-174.93%
FCF Margin
-20544.60%-19325.80%0.00%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2024
Period EndingAug '26 Dec '25 Dec '24 Mar '24
PS Ratio
119.86394.9310.72-